The 'dovetail' partnership meant to turn Boston Children's into a hub for gene therapy startups

ElevateBio, a privately held biotech with hefty financial backing, has formed a five-year alliance with Boston Children's Hospital that could lead to the creation of several new gene and cell therapy startups.